Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sheng-Zhang Lin
Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Antitumor and Apoptosis-Promoting Properties of Emodin, an Anthraquinone Derivative From Rheum Officinale Baill, Against Pancreatic Cancer in Mice via Inhibition of Akt Activation
International Journal of Oncology
Cancer Research
Oncology
Related publications
TrkB Promotes Laryngeal Cancer Metastasis via Activation PI3K/AKT Pathway
Oncotarget
Oncology
miR‑494‑3p Promotes the Progression of Endometrial Cancer by Regulating the PTEN/PI3K/AKT Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway
Chinese Medicine
Inhibition of Invasion in Pancreatic Cancer Cells by Conjugate of EPA With Β3,3-Pip-Oh via PI3K/Akt/NF-kB Pathway
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
UNBS5162 Inhibits Colon Cancer Growth via Suppression of PI3K/Akt Signaling Pathway
Medecine/Sciences
Biochemistry
Medicine
Genetics
Molecular Biology
Up-Regulation of IGF2BP2 by Multiple Mechanisms in Pancreatic Cancer Promotes Cancer Proliferation by Activating the PI3K/Akt Signaling Pathway
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Effect of Dexmedetomidine on the Cognitive Function of Patients Undergoing Gastric Cancer Surgery by Regulating the PI3K/AKT Signaling Pathway
Oncology Letters
Cancer Research
Oncology
Cystatin SN Affects Cell Proliferation by Regulating the ERα/PI3K/AKT/ERα Loopback Pathway in Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
MicroRNA-511 Inhibits Malignant Behaviors of Breast Cancer by Directly Targeting SOX9 and Regulating the PI3K/Akt Pathway
International Journal of Oncology
Cancer Research
Oncology